The Hatter Cardiovascular Institute at University College London initiated a series of webinars earlier this year to discuss & debate SGLT2 inhibitors & GLP-1 analogues in the management of Diabetes & Cardio-Renal disease. We are pleased to present the second of 2 follow-on webinars as outlined below.
**WEBINAR 2 of 2**
Recognising the importance of informing clinical trainees early in their careers, this is the next in a series of meetings created to address this need, with the programme presenting insight directly from SpR level specialists in these areas . Trainees in the specialities of Cardiology, Nephrology and Diabetes are invited to attend.
All interested trainees simply need to register their interest and join us on FRIDAY the 24th September, 2021 from 12pm for the webinar which should last approximately 1 to 1.5 hours. THERE IS NO CHARGE TO ATTEND.
Webinar Chairpersons: Professors Derek Yellon, John Cunningham & Stephanie Baldeweg
1. Emerging therapies affecting cardiovascular, renal and metabolic medicine?
Prof Mansoor Husain, University of Toronto, Canada
2. SpR Case presentations: Out of my comfort zone!
(i) Cardiovascular – Dr Ali Rauf, Cardiology SpR
How do I handle a patient with renal/diabetic co-morbidities?
(ii) Renal – Dr Tamer Rezk, Nephrology SpR
How do I handle a patient with cardiac/diabetic co-morbidities?
(iii) Metabolic – Dr Eleni Armeni, Diabetes and Endocrinology SpR
How do I handle a patient with cardiac & renal co-morbidities?
5. Breakout Discussions by Trainees